Takeda Pharmaceutical Company Limited - PE Ratio
TKPHF
Price:
$32.48
Market Cap:
$7.79T
Takeda Pharmaceutical Company Limited, an established global biopharmaceutical entity founded in 1781 and based in Tokyo, Japan, is comprehensively involved in the entire process of bringing new medicines to market. This includes the research, development, production, commercialization, and external licensing of its pharmaceutical products across a vast international footprint, encompassing Japan, the United States, Europe, Canada, Latin America, Russia, and other parts of Asia. The company concentrates its therapeutic endeavors on key medical areas such as digestive health (gastroenterology), rare disorders, treatments derived from blood plasma, cancer care (oncology), and neurological cond...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2008-06-25
Stock Exchange
OTC
Ticker
TKPHF
PE Ratio
[43.31]
ROE
[2.61%]
Current Ratio
[1.27]
Dividend Yield
[4.05%]
Enterprise Value
[12.08T]
Dividend History
The PE Ratio as of June 2026 (TTM) for Takeda Pharmaceutical Company Limited (TKPHF) is 43.31
According to Takeda Pharmaceutical Company Limited’s latest financial reports and current stock price. The company's current PE Ratio is 43.31. This represents a change of -185.40% compared to the average of -50.72 of the last 4 quarters.
Takeda Pharmaceutical Company Limited (TKPHF) Historical PE Ratio (quarterly & annually)
How has TKPHF PE Ratio performed in the past?
The mean historical PE Ratio of Takeda Pharmaceutical Company Limited over the last ten years is 45.72. The current 43.31 PE Ratio has changed 9.37% with respect to the historical average. Over the past ten years (40 quarters), TKPHF's PE Ratio was at its highest in in the March 2020 quarter at 745.05. The PE Ratio was at its lowest in in the March 2024 quarter at -541.54.
Average
45.72
Median
40.35
Minimum
16.55
Maximum
116.44
Takeda Pharmaceutical Company Limited (TKPHF) PE Ratio by Quarter and Year
Discovering the peaks and valleys of Takeda Pharmaceutical Company Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 203.68%
Maximum Annual PE Ratio = 116.44
Minimum Annual Increase = -85.78%
Minimum Annual PE Ratio = 16.55
| Year | PE Ratio | Change |
|---|---|---|
| 2026 | 46.52 | -27.94% |
| 2025 | 64.56 | 42.94% |
| 2024 | 45.16 | 112.10% |
| 2023 | 21.29 | -10.43% |
| 2022 | 23.77 | 43.61% |
| 2021 | 16.55 | -85.78% |
| 2020 | 116.44 | 77.06% |
| 2019 | 65.76 | 203.68% |
| 2018 | 21.65 | -39.06% |
| 2017 | 35.54 | -29.25% |
Takeda Pharmaceutical Company Limited (TKPHF) Average PE Ratio
How has TKPHF PE Ratio performed in the past?
The current PE Ratio of Takeda Pharmaceutical Company Limited (TKPHF) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
52.08
5-year avg
40.26
10-year avg
45.72
Takeda Pharmaceutical Company Limited (TKPHF) PE Ratio vs. Peers
How is TKPHF’s PE Ratio compared to its peers?
Takeda Pharmaceutical Company Limited’s PE Ratio is greater than Haleon plc (29.17), greater than Chalice Brands Ltd. (0), greater than Ipsen S.A. (29.14), greater than Daiichi Sankyo Company, Limited (18.10), greater than WuXi AppTec Co., Ltd. (14.49), greater than Daiichi Sankyo Company, Limited (18.10), greater than Sandoz Group AG (39.54), greater than WuXi AppTec Co., Ltd. (14.49), greater than HOYA Corporation (36.58), greater than Lonza Group AG (-127.22),
| Company | PE Ratio | Market cap |
|---|---|---|
| 29.17 | $39.33B | |
| 0 | $6.66K | |
| 29.14 | $57.98B | |
| 18.10 | $30.21B | |
| 14.49 | $46.64B | |
| 18.10 | $30.79B | |
| 39.54 | $36.48B | |
| 14.49 | $48.06B | |
| 36.58 | $56.70B | |
| -127.22 | $43.55B |
Build a custom stock screener for Takeda Pharmaceutical Company Limited (TKPHF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Takeda Pharmaceutical Company Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Takeda Pharmaceutical Company Limited (TKPHF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Takeda Pharmaceutical Company Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is Takeda Pharmaceutical Company Limited's PE Ratio?
How is the PE Ratio calculated for Takeda Pharmaceutical Company Limited (TKPHF)?
What is the highest PE Ratio for Takeda Pharmaceutical Company Limited (TKPHF)?
What is the 3-year average PE Ratio for Takeda Pharmaceutical Company Limited (TKPHF)?
What is the 5-year average PE Ratio for Takeda Pharmaceutical Company Limited (TKPHF)?
How does the current PE Ratio for Takeda Pharmaceutical Company Limited (TKPHF) compare to its historical average?